Ten additional solid cancers such as prostate, gastric, ovarian, colon, cervical, renal clear cell carcinoma, osteosarcoma, bladder, thyroid and LSCC cancers are known to be dependent on deficiency in KAI1/CD82 expression. Here, CD82 is linked to cancer.